OTCMKTS:STLT

Spotlight Innovation Stock Forecast, Price & News

$0.02
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.02
Now: $0.02▼
$0.02
50-Day Range
$0.01
MA: $0.02▼
$0.02
52-Week Range
$0.00
Now: $0.02▼
$0.04
VolumeN/A
Average Volume19,138 shs
Market Capitalization$771,525.00
P/E RatioN/A
Dividend YieldN/A
Beta-105.24
Spotlight Innovation Inc., a pharmaceutical company, acquires and develops proprietary therapies to address unmet medical needs with an emphasis on rare, emerging, and neglected diseases. It identifies in-licensing opportunities and manages product development through partnerships with universities, medical schools, contract research organizations, and contract manufacturing organizations, as well as pursues product commercialization opportunities, including out-licensing and strategic partnerships. The company is developing Crotoxin, which is in Phase I clinical study for the treatment of cancer. It also develops various compounds for the treatment of viral infections, including Zika virus infection; and products derived from cobra venom to treat chronic pain. Spotlight Innovation Inc. has a license agreement with Indiana University Research and Technology Corporation to commercialize STL-182, an orally-available small molecule that might have therapeutic potential for treating spinal muscular atrophy. The company is based in Urbandale, Iowa.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:STLT
Previous Symbol
CUSIPN/A
CIK1388486
Webwww.spotlightinnovation.com
Phone515-274-9087
Employees4
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares34,290,000
Market Cap$771,525.00
Next Earnings DateN/A
OptionableNot Optionable

Headlines

World Acne Market Spotlight Report 2021: 10-Year...
April 9, 2021 |  benzinga.com
Mercedes in the Morning's Zoom Room Spotlight with Alex Gaskarth from All Time Low
April 8, 2021 |  msn.com
Veteran Publicist Erica Gray Launches The Spotlight Company
April 7, 2021 |  msn.com
Transcript: Oscar® Spotlight: “The Mole Agent”
April 7, 2021 |  msn.com
Transcript: Oscar® Spotlight: “Time”
April 6, 2021 |  msn.com
Pokémon Go Spotlight Hour features shiny Buneary tonight
April 6, 2021 |  msn.com
Singapore Sportstar Spotlight: Irfan Fandi, Football
April 6, 2021 |  msn.com
All Pokémon Go Spotlight Hours (April 2021)
April 5, 2021 |  msn.com
Education Spotlight: This MCOE program is all about empowering young adults
April 1, 2021 |  msn.com
Former Spotlight Music Building in Heart of Fort Collins Purchased by Appliance Factory & Mattress Kingdom
April 1, 2021 |  finance.yahoo.com
Listen to the Audacy Alternalido Artist Spotlight with Natalia Lafourcade
March 31, 2021 |  msn.com
Transcript: Oscar® Spotlight: “Crip Camp”
March 31, 2021 |  msn.com
Garden City High School Senior Spotlight: Jessica Poz
March 30, 2021 |  msn.com
Small Biz Spotlight: MasPanadas
March 26, 2021 |  bizjournals.com
DPR Ian Is Reframing Mental Disorders as 'Superpowers': Emerging Artists Spotlight
March 26, 2021 |  msn.com
Sports Spotlight : Becca Nitsch
March 24, 2021 |  msn.com
WITN Sports Spotlight: Jayden Willis
March 23, 2021 |  msn.com
Meryl Streep, Mary-Louise Parker & Carla Gugino Join ‘Spotlight On Plays’ Virtual Benefit Series
March 23, 2021 |  msn.com
Community Spotlight: Hope Distributed
March 22, 2021 |  msn.com
Learning Ally's Spotlight on Dyslexia Virtual Conference Presents Leading Experts on Literacy and the Science of Reading
March 22, 2021 |  finance.yahoo.com
See More Headlines

MarketRank™

Overall MarketRank™

0.52 out of 5 stars

Medical Sector

1496th out of 2,011 stocks

Pharmaceutical Preparations Industry

636th out of 772 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.02
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STLT News and Ratings via Email

Sign-up to receive the latest news and ratings for STLT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Spotlight Innovation (OTCMKTS:STLT) Frequently Asked Questions

What stocks does MarketBeat like better than Spotlight Innovation?

Wall Street analysts have given Spotlight Innovation a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Spotlight Innovation wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Spotlight Innovation's stock price been impacted by COVID-19 (Coronavirus)?

Spotlight Innovation's stock was trading at $0.0040 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, STLT shares have increased by 462.5% and is now trading at $0.0225.
View which stocks have been most impacted by COVID-19.

Who are Spotlight Innovation's key executives?

Spotlight Innovation's management team includes the following people:
  • Mr. John Michael Krohn, Chairman, CEO, Pres, COO & Interim CFO (Age 62, Pay $206.44k)
  • Mr. Rene Erickson, VP of Corp. Communications
  • Dr. Geoffrey M. Laff Ph.D., Sr. VP of Bus. Devel.

Who are some of Spotlight Innovation's key competitors?

Some companies that are related to Spotlight Innovation include Boston Therapeutics (BTHE), Innovus Pharmaceuticals (INNVD), RespireRx Pharmaceuticals (RSPI), Inspyr Therapeutics (NSPX), VIVUS (VVUSQ), ImmunoCellular Therapeutics (IMUCD), Capstone Therapeutics (CAPS), W World (WWHC), ImmunoCellular Therapeutics (IMUC), Cardax (CDXI), Earth Science Tech (ETST), Melinta Therapeutics (MLNTQ), Achaogen (AKAOQ), Aeolus Pharmaceuticals (AOLS) and Cotinga Pharmaceuticals (COTQF).
View all of STLT's competitors.

What other stocks do shareholders of Spotlight Innovation own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Spotlight Innovation investors own include Halliburton (HAL), Caterpillar (CAT), Babcock & Wilcox Enterprises (BW), Alibaba Group (BABA), The Boeing (BA), Ascent Solar Technologies (ASTI), Arch Therapeutics (ARTH), Amerigo Resources (ARREF), Blue Apron (APRN) and Africa Oil (AOIFF).

What is Spotlight Innovation's stock symbol?

Spotlight Innovation trades on the OTCMKTS under the ticker symbol "STLT."

How do I buy shares of Spotlight Innovation?

Shares of STLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Spotlight Innovation's stock price today?

One share of STLT stock can currently be purchased for approximately $0.02.

How much money does Spotlight Innovation make?

Spotlight Innovation has a market capitalization of $771,525.00.

How many employees does Spotlight Innovation have?

Spotlight Innovation employs 4 workers across the globe.

What is Spotlight Innovation's official website?

The official website for Spotlight Innovation is www.spotlightinnovation.com.

Where are Spotlight Innovation's headquarters?

Spotlight Innovation is headquartered at 11147 AURORA AVENUE AURORA BUSINESS PARK BUILDING 3, URBANDALE IA, 50322.

How can I contact Spotlight Innovation?

Spotlight Innovation's mailing address is 11147 AURORA AVENUE AURORA BUSINESS PARK BUILDING 3, URBANDALE IA, 50322. The company can be reached via phone at 515-274-9087 or via email at [email protected]


This page was last updated on 4/12/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.